EMILY KENDALL: Open Payments
NPI 1396923322 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,683 in 132 payments from 19 companies in 2025. Trend: 2023 $348 · 2024 $2,242 · 2025 $2,683
Food & beverage: $2,606Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $885 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $275 |
| Lilly USA, LLC | 13 | $223 |
| Aimmune Therapeutics, Inc. | 9 | $195 |
| Janssen Biotech, Inc. | 7 | $176 |
| Regeneron Healthcare Solutions, Inc. | 3 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $148 |
| QOL Medical, LLC | 9 | $142 |
| Madrigal Pharmaceuticals | 5 | $82 |
| Phathom Pharmaceuticals, Inc. | 5 | $71 |
Products named: SKYRIZI, XIFAXAN, RINVOQ, OMVOH, DUPIXENT, ZENPEP, TREMFYA, ENTYVIO.
Industry payments across NC — which companies pay providers there.
